Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies
Publication Date
2024
Content Type
Article
PubMed ID:
Citation
Cancer Research Communications (2024) 4(5):1369-1379
2024
Article
Cancer Research Communications (2024) 4(5):1369-1379